3-(2,5-Dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 直链 1,3-二芳基丙烷
• 英文名称: 3-(2,5-Dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
• 化学式: C₁₈H₁₈O₄
• 分子量: 298.339
• InChiKey: SVNGLYGVFCJUPR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  22
• 可旋转键数：
  6
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  44.8
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  3-(2,5-Dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one 、 肼甲酰亚胺酰胺一氯化氢 在 盐酸 作用下， 以 四氢呋喃 、 水 为溶剂， 以29.45%的产率得到(Z)-2-((E)-3-(2,5-dimethoxyphenyl)-1-(4-methoxyphenyl)allylidene)hydrazinecarboximidamide
  参考文献：
  名称：

  Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors

  摘要：

  BACE-1 (beta-secretase) is considered to be one of the promising targets for treatment of Alzheimer's disease as it catalyzes the rate limiting step of A beta-42 production. Herein, we report a novel class of allylidene hydrazinecarboximidamide derivatives as moderately potent BACE-1 inhibitors, having aminoguanidine substitution on allyl linker with two aromatic groups on either side. A library of derivatives was designed based on the docking studies, synthesized and evaluated for BACE-1 inhibition in vitro. The designed ligands displayed interactions with the catalytic aspartate dyad through guanidinium functionality. Further, the aromatic rings placed on either side of the linker occupied S1 and S3 active site regions contributing to the activity. These ligands were also predicted to follow Lipinski rule and cross blood brain barrier. Compound 2.21, having high docking score, was found to be most active with IC50 of 6.423 mu M indicating good correlation with docking prediction. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmcl.2015.11.044
• 作为产物：
  描述：

  2,5-二甲氧基苯甲醛 、 对甲氧基苯乙酮 在 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 生成 3-(2,5-Dimethoxyphenyl)-1-(4-methoxyphenyl)prop-2-en-1-one
  参考文献：
  名称：

  新型吡唑啉的合成，细胞毒性和碳酸酐酶抑制活性。

  摘要：

  合成了一系列聚甲氧基化的吡唑啉苯磺酰胺，研究了它们对肿瘤和非肿瘤细胞系的细胞毒活性以及对碳酸酐酶同工酶（hCA I和hCA II）的抑制作用。尽管化合物的肿瘤选择性（TS）小于参考化合物5-氟尿嘧啶和美法仑，但通过细胞毒性试验判断，两种类型的细胞均可以证明三甲氧基衍生物4、5和6比二甲氧基衍生物2和3更具选择性。从牙龈组织。化合物6（4- [3-（4-甲氧基苯基）-5-（3,4,5-三甲氧基苯基）-4,5-二氢-1H-吡唑-1-基]苯磺酰胺）显示出最高的TS值和可以被认为是该系列的进一步研究的先导分子。

  DOI：

  10.1080/14756366.2016.1217852

文献信息

• Design, synthesis, biological evaluation of 3,5-diaryl-4,5-dihydro-1H-pyrazole carbaldehydes as non-purine xanthine oxidase inhibitors: Tracing the anticancer mechanism via xanthine oxidase inhibition
  作者：Gaurav Joshi、Manisha Sharma、Sourav Kalra、Navnath S. Gavande、Sandeep Singh、Raj Kumar

  DOI：10.1016/j.bioorg.2020.104620

  日期：2021.2

  (2a-2x) as xanthine oxidase inhibitors (XOIs). A docking model was developed for the prediction of XO inhibitory activity of our novel compounds. Furthermore, our compounds anticancer activity results in low XO expression and XO-harboring cancer cells both in 2D and 3D-culture models are presented and discussed. Among the array of synthesized compounds, 2b and 2m emerged as potent XO inhibitors having

  黄嘌呤氧化酶 (XO) 主要用于开发抗高尿酸血症/抗痛风剂，因为它催化黄嘌呤和次黄嘌呤转化为尿酸。由于催化过程中活性氧 (ROS) 的产生和致癌物质的代谢活化，XO 在各种癌症中的过度表达非常相关。在此，我们报告了一系列 3,5-二芳基-4,5-二氢-1 H-吡唑甲醛衍生物 ( 2a - 2x) 作为黄嘌呤氧化酶抑制剂 (XOI)。开发了一种对接模型，用于预测我们的新型化合物的 XO 抑制活性。此外，我们的化合物抗癌活性导致 2D 和 3D 培养模型中的低 XO 表达和 XO 携带癌细胞。合成的化合物的阵列中，图2b和2米成为具有IC强效抑制剂XO 50值分别为 9.32 ± 0.45 µM 和 10.03 ± 0.43 µM。这两种化合物均诱导细胞凋亡，在 G1 期停止细胞周期进程，提高 ROS 水平，改变线粒体膜电位，并抑制抗氧化酶。由于我们的化合物诱导的氧化应激增加，细胞中 miRNA
• Synthesis, cytotoxic, and carbonic anhydrase inhibitory effects of new 2‐(3‐(4‐methoxyphenyl)‐5‐(aryl)‐4,5<scp>‐dihydro‐1<i>H</i></scp>‐pyrazol‐1‐yl)benzo[<i>d</i>]thiazole derivatives
  作者：Mehtap Tugrak、Halise Inci Gul、Hiroshi Sakagami、Ilhami Gulcin

  DOI：10.1002/jhet.3985

  日期：2020.7

  2‐(3‐[4‐Methoxyphenyl]‐5‐aryl‐4,5‐dihydro‐1H ‐pyrazol‐1‐yl)benzo[d ]thiazoles (1b‐7b ) were synthesized for the first time except 1b , and spectral methods such as 1H NMR, 13C NMR and HRMS were utilized to illuminate the chemical structures of the synthesized compounds. Phenyl (1b ), 2‐methoxyphenyl (2b ), 4‐methoxyphenyl (3b ), 4‐methoxy‐3‐hydroxyphenyl (4b ), 2,5‐dimethoxyphenyl (5b ), 3,4,5‐trimethoxyphenyl

  除1b和1b以外，首次合成了2-（3- [4-甲氧基苯基] -5-芳基-4,5-二氢-1 H-吡唑-1-基）苯并[ d ]噻唑（1b-7b）。光谱方法，例如1 H NMR，13 C NMR和HRMS被用于阐明合成化合物的化学结构。苯基（1b），2-甲氧基苯基（2b），4-甲氧基苯基（3b），4-甲氧基-3-羟基苯基（4b），2,5-二甲氧基苯基（5b），3,4,5-三甲氧基苯基（6b），或噻吩-2-基（7b）用作芳基部分。评估了化合物对人碳酸酐酶I和II酶（hCA I和hCA II）的抑制作用。所述化合物对人类口腔鳞状细胞癌和人类正常口腔细胞的体外细胞毒性作用通过MTT进行。化合物（1b-7b）的Ki值为36.87±11.62-66.24±2.99μM（hCA I）和22.66±1.41-89.95±6.25μM（hCA II）。朝向hCA I的化合物1b（Ki = 36.87±11.62μM
• Biological evaluation and synthesis of new pyrimidine-2(1H)-ol/-thiol derivatives derived from chalcones using the solid phase microwave method
  作者：SEDA FANDAKLI、NURAN KAHRİMAN、TAYYİBE BEYZA YÜCEL、ŞENGÜL ALPAY KARAOĞLU、NURETTİN YAYLI

  DOI：10.3906/kim-1711-9

  日期：——

  Twenty-five new hydroxyand methoxy-substituted 4,6-diarylpyrimidin-2(1H)-ol (20–34) and 4,6-diarylpyrimidine-2(1H)-thiol derivatives (35–44) were synthesized from the reaction of the corresponding 1,3-diaryl-2-propene-1one compounds (1–19) with urea or thiourea using the solid-phase microwave method. All the new synthetic compounds (20–44) were evaluated with regard to their α -glucosidase activity

  通过以下反应合成了二十五个新的羟基和甲氧基取代的4,6-二芳基嘧啶-2（1H）-醇（20-34）和4,6-二芳基嘧啶-2（1H）-硫醇衍生物（35-44）。使用固相微波方法，将相应的1,3-二芳基-2-丙烯-1酮化合物（1-19）与尿素或硫脲一起使用。对所有新的合成化合物（20-44）的α-葡萄糖苷酶活性进行了评估。但是，只有化合物22–25、27、31、34、35、37和40表现出比标准阿卡波糖更大的抑制作用。活性化合物的IC50值在2.36和13.34μM之间。还筛选了25种新化合物的体外胰腺脂肪酶活性，发现化合物20–27和35–39具有活性。在这些化合物中，26、27和39在0.40±0.06、0.26±0.07，和0.29±0.026μM。对所有新化合物（20-44）的九种测试微生物的体外抗菌活性进行了评估。经测定，化合物20-24和35-39在检测的细菌病原菌中对革兰氏阳性粪便
• Synthesis, cytotoxicity and carbonic anhydrase inhibitory activities of new pyrazolines
  作者：Kaan Kucukoglu、Fatih Oral、Tevfik Aydin、Cem Yamali、Oztekin Algul、Hiroshi Sakagami、Ilhami Gulcin、Claudiu T. Supuran、Halise Inci Gul

  DOI：10.1080/14756366.2016.1217852

  日期：2016.11.4

  their cytotoxic activities on tumor and non-tumor cell lines and inhibitory effects on carbonic anhydrase isoenzymes (hCA I and hCA II). Although tumor selectivity (TS) of the compounds were less than the reference compounds 5-Fluorouracil and Melphalan, trimethoxy derivatives 4, 5, and 6 were more selective than dimethoxy derivatives 2 and 3 as judged by the cytotoxicity assay with the cells both types

  合成了一系列聚甲氧基化的吡唑啉苯磺酰胺，研究了它们对肿瘤和非肿瘤细胞系的细胞毒活性以及对碳酸酐酶同工酶（hCA I和hCA II）的抑制作用。尽管化合物的肿瘤选择性（TS）小于参考化合物5-氟尿嘧啶和美法仑，但通过细胞毒性试验判断，两种类型的细胞均可以证明三甲氧基衍生物4、5和6比二甲氧基衍生物2和3更具选择性。从牙龈组织。化合物6（4- [3-（4-甲氧基苯基）-5-（3,4,5-三甲氧基苯基）-4,5-二氢-1H-吡唑-1-基]苯磺酰胺）显示出最高的TS值和可以被认为是该系列的进一步研究的先导分子。
• Rational design, synthesis and in vitro evaluation of allylidene hydrazinecarboximidamide derivatives as BACE-1 inhibitors
  作者：Priti Jain、Pankaj K. Wadhwa、Shilpa Rohilla、Hemant R. Jadhav

  DOI：10.1016/j.bmcl.2015.11.044

  日期：2016.1

  BACE-1 (beta-secretase) is considered to be one of the promising targets for treatment of Alzheimer's disease as it catalyzes the rate limiting step of A beta-42 production. Herein, we report a novel class of allylidene hydrazinecarboximidamide derivatives as moderately potent BACE-1 inhibitors, having aminoguanidine substitution on allyl linker with two aromatic groups on either side. A library of derivatives was designed based on the docking studies, synthesized and evaluated for BACE-1 inhibition in vitro. The designed ligands displayed interactions with the catalytic aspartate dyad through guanidinium functionality. Further, the aromatic rings placed on either side of the linker occupied S1 and S3 active site regions contributing to the activity. These ligands were also predicted to follow Lipinski rule and cross blood brain barrier. Compound 2.21, having high docking score, was found to be most active with IC50 of 6.423 mu M indicating good correlation with docking prediction. (C) 2015 Elsevier Ltd. All rights reserved.